Follow-up investigation into the combined detection of inhibitors of the activin receptor signaling pathways (IASPs) by LC-HRMS/MS for doping control
Abstract Cytokines of the transforming growth factor beta (TGF-β) superfamily, including myostatin (MSTN), activin A (ActA), and growth differentiation factor-11 (GDF-11), regulate biological processes such as muscle growth, erythropoiesis, and tissue repair through activin type II receptors A and B (ActRIIA/ActRIIB). Inhibitors of activin receptor signaling pathways (IASPs) are prohibited by the World Anti-Doping Agency (WADA) due to their potential performance-enhancing effects. Building on a previously published multiplexed liquid chromatography-high resolution (tandem) mass spectrometry (LC-HRMS/MS) assay for the detection of nine IASPs in serum and plasma, this study expanded the method to include five additional IASPs: the therapeutic antibodies Emugrobart and Trevogrumab, and the fusion proteins Taldefgrobep alfa, Efmitermant alfa and Cibotercept. Sample preparation involved ammonium sulfate precipitation, multi-ligand (immuno-)affinity purification with magnetic beads, and tryptic digestion. Target analytes were detected based on two to four proteospecific peptides per analyte. This work reports the first LC-HRMS/MS detection strategy for these analytes in an anti-doping context. The method was validated and proved to be specific and sensitive (LODs: 22-85 ng/mL). The assay is suitable for routine anti-doping testing as an initial testing procedure, is readily adaptable to easily include novel analytes and potentially enables retrospective analysis for newly emerging IASPs.
Authors
- Mario Thevis (ORCID: https://orcid.org/0000-0002-1535-6451)
- Katja Walpurgis (ORCID: https://orcid.org/0000-0003-1194-8158)
- Panagiotis Sakellariou (ORCID: https://orcid.org/0009-0005-1005-738X)
- Andreas Thomas
Institutions
- German Sport University Cologne (DE)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1038/s41598-026-78914-3
- Primary Topic
- Doping in Sports
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Partnership for Clean Competition